Zura Bio announces global Phase 2 TibuSURE trial for systemic sclerosis treatment

Bristol Myers Squibb gains EU approval for Opdivo and Yervoy to treat first-line metastatic colorectal cancer

Eli Lilly and Co receives approval from FDA for Zepbound

YolTech Therapeutics updates data from Phase I/IIa clinical trial of YOLT-201

AstraZeneca's Tagrisso gains EU approval for advanced lung cancer treatment

Novo Nordisk's CagriSema shows superior weight loss in obesity trial

GSK's Jemperli-Zejula combination shows promise in ovarian cancer

Sapience Therapeutics' ST316 receives US FDA Orphan Drug Designation

Ionis Pharmaceuticals' TRYNGOLZA receives US FDA approval

BioArctic licenses PyroGlu-Aβ antibody programme to Bristol Myers Squibb

Thor Medical signs supply deal with AdvanCell

MOBILion Systems collaborates with Dr Oliver Schmitz to enhance metabolomics analysis

Abilita and Orion partner on antibody therapeutics for oncology and pain

Pharus Diagnostics unveils liquid biopsy test for early pancreatic cancer detection

Mendus reports positive topline data from ovarian cancer trial